A curcumin (turmeric) and artemisinin-based oral spray has been proposed as a treatment for COVID-19 patients and a clinical trial will be conducted, ASX-listed phytocannabinoid firm MGC Pharmaceuticals has revealed.
CLICK> TO BOOST YOUR IMMUNE SYSTEM!
){kind=link}
Comments
Comments are disabled for this post.